Endovab's mission is to develop and provide innovative endovascular tools and techniques that improve vascular treatments through research and clinical experience. Endovab was founded in 2009 and has its head office in Stockholm and a research laboratory in Uppsala. The company’s founder and innovation lead MD, Ph.D. Krister Liungman, Head of Vascular Surgery at Uppsala University Hospital, has more than 25 years of experience in treating vascular disease. With experienced backers and a driven team, Endovab is committed to its objective of improving treatment within the field of endovascular surgery.
View Top Employees from Endovascular Development AB| Website | http://www.endovab.com |
| Revenue | $1 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2009 |
| Address | 29 Stockholm 7TR, Stockholm 111 56, SE |
| Technologies |
HTML,
jQuery,
Microsoft Outlook
+4 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Endovascular Development AB employee's phone or email?
Endovascular Development AB Questions
The Endovascular Development AB annual revenue was $1 million in 2024.
Anja Kivimäki is the Vice President Internal Affairs of Endovascular Development AB.
1 people are employed at Endovascular Development AB.
The NAICS codes for Endovascular Development AB are [33, 339].
The SIC codes for Endovascular Development AB are [384, 38].
Top Endovascular Development AB Employees
Related Companies
